Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas.

Li X, Singh K, Luo Z, Mejia-Cordova M, Jamalpour M, Lindahl B, Zhang G, Sandler S, Welsh M.

Oncotarget. 2018 Apr 10;9(27):18720-18733. doi: 10.18632/oncotarget.24643. eCollection 2018 Apr 10.

2.

Increased Interleukin-35 Levels in Patients With Type 1 Diabetes With Remaining C-Peptide.

Espes D, Singh K, Sandler S, Carlsson PO.

Diabetes Care. 2017 Aug;40(8):1090-1095. doi: 10.2337/dc16-2121. Epub 2017 Jun 15.

PMID:
28620093
3.

Bifidobacterium: An Emerging Clinically Significant Metronidazole-resistant Anaerobe of Mixed Pyogenic Infections.

Butta H, Sardana R, Vaishya R, Singh KN, Mendiratta L.

Cureus. 2017 Apr 4;9(4):e1134. doi: 10.7759/cureus.1134.

4.

The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.

Singh K, Sandler S, Espes D.

J Diabetes Res. 2017;2017:6192896. doi: 10.1155/2017/6192896. Epub 2017 Mar 21.

5.

Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis.

Digre A, Singh K, Åbrink M, Reijmers RM, Sandler S, Vlodavsky I, Li JP.

Sci Rep. 2017 Apr 12;7:46229. doi: 10.1038/srep46229.

6.

PAN substitutions A37S, A37S/I61T and A37S/V63I attenuate the replication of H7N7 influenza A virus by impairing the polymerase and endonuclease activities.

Hu M, Yuan S, Ye ZW, Singh K, Li C, Shuai H, Fai N, Chow BK, Chu H, Zheng BJ.

J Gen Virol. 2017 Mar;98(3):364-373. doi: 10.1099/jgv.0.000717. Epub 2017 Apr 1.

PMID:
28113045
7.

PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.

Hu M, Yuan S, Zhang K, Singh K, Ma Q, Zhou J, Chu H, Zheng BJ.

Virology. 2017 Jan 15;501:92-101. doi: 10.1016/j.virol.2016.11.008. Epub 2016 Nov 24.

8.

Amino acid substitutions V63I or A37S/I61T/V63I/V100A in the PA N-terminal domain increase the virulence of H7N7 influenza A virus.

Hu M, Chu H, Zhang K, Singh K, Li C, Yuan S, Chow BK, Song W, Zhou J, Zheng BJ.

Sci Rep. 2016 Nov 25;6:37800. doi: 10.1038/srep37800.

9.

Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.

Yuan S, Chu H, Ye J, Singh K, Ye Z, Zhao H, Kao RY, Chow BK, Zhou J, Zheng BJ.

Antiviral Res. 2017 Jan;137:58-66. doi: 10.1016/j.antiviral.2016.11.005. Epub 2016 Nov 10.

PMID:
27840201
10.

Correction: Structure-Activity Relationship Studies of N- and C-Terminally Modified Secretin Analogs for the Human Secretin Receptor.

Singh K, Senthil V, Arokiaraj AW, Leprince J, Lefranc B, Vaudry D, Allam AA, Ajarem J, Chow BK.

PLoS One. 2016 Oct 26;11(10):e0165770. doi: 10.1371/journal.pone.0165770. eCollection 2016.

11.

Glycyrrhizic Acid Reduces Heart Rate and Blood Pressure by a Dual Mechanism.

Singh K, Zaw AM, Sekar R, Palak A, Allam AA, Ajarem J, Chow BK.

Molecules. 2016 Sep 27;21(10). pii: E1291.

12.

Peptide-Mediated Interference of PB2-eIF4G1 Interaction Inhibits Influenza A Viruses' Replication in Vitro and in Vivo.

Yuan S, Chu H, Ye J, Hu M, Singh K, Chow BK, Zhou J, Zheng BJ.

ACS Infect Dis. 2016 Jul 8;2(7):471-7. doi: 10.1021/acsinfecdis.6b00064. Epub 2016 Jun 13.

PMID:
27626099
13.

A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.

Yuan S, Chu H, Zhang K, Ye J, Singh K, Kao RY, Chow BK, Zhou J, Zheng BJ.

J Antimicrob Chemother. 2016 Sep;71(9):2489-97. doi: 10.1093/jac/dkw194. Epub 2016 Jun 5.

PMID:
27272726
14.

In Silico Approach for SAR Analysis of the Predicted Model of DEPDC1B: A Novel Target for Oral Cancer.

Ahuja P, Singh K.

Adv Bioinformatics. 2016;2016:3136024. doi: 10.1155/2016/3136024. Epub 2016 Feb 29.

15.

A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.

Yuan S, Chu H, Singh K, Zhao H, Zhang K, Kao RY, Chow BK, Zhou J, Zheng BJ.

Sci Rep. 2016 Mar 9;6:22880. doi: 10.1038/srep22880.

16.

Structure-Activity Relationship Studies of N- and C-Terminally Modified Secretin Analogs for the Human Secretin Receptor.

Singh K, Senthil V, Arokiaraj AW, Leprince J, Lefranc B, Vaudry D, Allam AA, Ajarem J, Chow BK.

PLoS One. 2016 Mar 1;11(3):e0149359. doi: 10.1371/journal.pone.0149359. eCollection 2016. Erratum in: PLoS One. 2016 Oct 26;11(10 ):e0165770.

17.

Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.

Yuan S, Chu H, Zhao H, Zhang K, Singh K, Chow BK, Kao RY, Zhou J, Zheng BJ.

Antiviral Res. 2016 Jan;125:34-42. doi: 10.1016/j.antiviral.2015.11.005. Epub 2015 Nov 22.

PMID:
26593979
18.

Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells.

Singh K, Kadesjö E, Lindroos J, Hjort M, Lundberg M, Espes D, Carlsson PO, Sandler S, Thorvaldson L.

Sci Rep. 2015 Jul 30;5:12633. doi: 10.1038/srep12633.

19.

Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis.

Oskarsson ME, Singh K, Wang J, Vlodavsky I, Li JP, Westermark GT.

J Biol Chem. 2015 Jun 12;290(24):15121-32. doi: 10.1074/jbc.M114.631697. Epub 2015 Apr 28.

20.

Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Yuan S, Zhang N, Singh K, Shuai H, Chu H, Zhou J, Chow BK, Zheng BJ.

Antimicrob Agents Chemother. 2015 Jul;59(7):4082-93. doi: 10.1128/AAC.00306-15. Epub 2015 Apr 27.

Supplemental Content

Loading ...
Support Center